Related Experiment Videos
Three-dimensional conformal therapy (3D-CRT) for prostate cancer
Cancer Treatment and Research
|January 1, 1996
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Radiologic validation of a fast neutron multileaf collimator.
Medical physics·2007
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
The 1989 patterns of care study for prostate cancer: five-year outcomes.
International journal of radiation oncology, biology, physics·2001
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer.
ACS applied materials & interfaces·2026
Protective effect of the bee bread on cadmium-induced testicular toxicity in rats.
Veterinary research forum : an international quarterly journal·2026
Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience.
Clinical and translational radiation oncology·2026
Efficacy and Safety of Sintilimab in Combination With Anlotinib and Chemoradiotherapy as First-Line Treatment for Driver Gene-Negative Oligometastatic Non-small Cell Lung Cancer: A Real-World Cohort Study.
Dose-response : a publication of International Hormesis Society·2026